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Introduction {#acn3536-sec-0005}
============

Stroke caused by an acute basilar artery (BA) occlusion is associated with poor clinical outcomes when treated conventionally.[1](#acn3536-bib-0001){ref-type="ref"}, [2](#acn3536-bib-0002){ref-type="ref"} Although the efficacy of endovascular therapies (EVT) over systemic thrombolysis has not been fully established,[2](#acn3536-bib-0002){ref-type="ref"}, [3](#acn3536-bib-0003){ref-type="ref"}, [4](#acn3536-bib-0004){ref-type="ref"}, [5](#acn3536-bib-0005){ref-type="ref"} achieving the reperfusion of BA territory might be crucial to improve the outcomes.[6](#acn3536-bib-0006){ref-type="ref"}, [7](#acn3536-bib-0007){ref-type="ref"}, [8](#acn3536-bib-0008){ref-type="ref"} Therefore, longer time windows are generally applied in the EVT for BA occlusion (up to 12--24 h from stroke onset), compared to the strokes in the anterior‐circulation.[9](#acn3536-bib-0009){ref-type="ref"} In this regard, investigating the factors that influence the outcomes after EVT is of fundamental value in demonstrating the clinical benefit of EVT and selecting the subjects who would benefit from EVT.

A recent study reported that the two main mechanisms of BA occlusion, in situ atherosclerotic thrombosis (ISAT) and embolism, may have a major influence on the response to EVT and long‐term outcomes.[6](#acn3536-bib-0006){ref-type="ref"}, [10](#acn3536-bib-0010){ref-type="ref"} Considering the distinct hemodynamic characteristic of BA compared to the anterior‐circulation arteries,[9](#acn3536-bib-0009){ref-type="ref"} the site of occlusion in BA segment may have a strong association with the underlying stroke mechanism and outcomes after EVT.[11](#acn3536-bib-0011){ref-type="ref"}

In this study, we hypothesized that the clinical outcomes would be different between the two underlying mechanisms of BA occlusion. We aimed to evaluate the impact of underlying mechanism of BA occlusion on the outcomes after EVT and the outcome factors associated with each mechanism. Furthermore, we tried to identify a radiologic parameter representing the site of occlusion and might be useful in the early distinguishment of the mechanism of BA occlusion.

Materials and Methods {#acn3536-sec-0006}
=====================

Study population {#acn3536-sec-0007}
----------------

From a prospectively acquired registry database of all consecutive in‐patients with an acute ischemic stroke in two tertiary hospitals between January 2010 and March 2017, 2020 patients with a posterior‐circulation stroke were initially recruited. Among them, 287 patients were diagnosed with acute BA occlusion and 201 patients underwent EVT for reperfusion. An acute BA occlusion was defined as a stroke with time from onset to groin puncture less than 24 h,[9](#acn3536-bib-0009){ref-type="ref"} using the onset time of symptoms consistent with the diagnosis of acute BA syndrome,[2](#acn3536-bib-0002){ref-type="ref"}, [8](#acn3536-bib-0008){ref-type="ref"} or the last time that the patient appeared normal if the exact onset was unidentifiable.[2](#acn3536-bib-0002){ref-type="ref"}, [4](#acn3536-bib-0004){ref-type="ref"} This study was reviewed and approved by the institutional review board of Seoul National University Hospital. The requirement for informed consent was waived because the patients\' medical information was de‐identified prior to use in our analysis.

Evaluation and treatment protocol {#acn3536-sec-0008}
---------------------------------

We obtained patients\' premorbid information including age, sex, cerebrovascular risk factor profiles, and antithrombotic medication history. Stroke severity was assessed using the National Institute‐of‐Health Stroke‐Scale (NIHSS) scores at the initial visit.

For the 52 (26.8%) cases of hyper‐acute BA strokes (\<4.5 h from the onset), intravenous tissue plasminogen activator (tPA, 0.6--0.9 mg/kg) was administered after obtaining the CT images. Due to the longer time windows applied for the EVT for BA occlusion (up to 12--24 h from stroke onset),[9](#acn3536-bib-0009){ref-type="ref"} MRI and MR angiography (MRA) images were obtained before the angiographic evaluation in most (191/194. 98.5%) cases, to evaluate the exact extent of ischemic involvement and the risk of stroke progression that could be prevented by the EVT.

All angiographic procedures were performed on a biplanar system (Integris Allura 12/12; Philips) via the transfemoral approach by two or more trained neuro‐interventionists. The devices used for mechanical thrombectomy were categorized as a stent retriever, including Solitaire (Covidien, Dublin, Ireland) and Trevo (Stryker, Mountain View, CA), and a non‐stent retriever such as MERCI (Stryker) and Penumbra (Penumbra, Alameda, CA).[4](#acn3536-bib-0004){ref-type="ref"} Intra‐arterial (IA) infusion of thrombolytic agents including pro‐urokinase, urokinase, tPA, or reteplace, balloon‐assisted angioplasty, or stent placement in the BA were performed complementary to the mechanical thrombectomy, based on the clinician\'s decision. We also recorded the use of anticoagulation agents or combined antithrombotic agents after EVT. Delayed reocclusion was designated as a deterioration of the neurological status associated with a documentation of reocclusion of BA on follow‐up evaluations such as CT angiography, MRA, or conventional angiography, after a successful reperfusion was decided at the end of the initial angiographic procedure.

Determination of the stroke mechanism {#acn3536-sec-0009}
-------------------------------------

We categorized the mechanism underlying BA occlusion into in situ atherosclerotic thrombosis (ISAT) and embolism, based on that this classification better discriminates the different clinical profiles and outcomes between the mechanisms than the traditionally used Trial of Org 10172 in Acute Stroke Treatment (TOAST) classification.[6](#acn3536-bib-0006){ref-type="ref"} Using the Stop Stroke Study TOAST (SSS‐TOAST) algorithm[12](#acn3536-bib-0012){ref-type="ref"} and the method introduced by Kim et al.[6](#acn3536-bib-0006){ref-type="ref"} with modification, evidences of ISAT mechanism from embolism were designated as: (1) a detection of moderate to severe (≥50%) stenosis or a stenosis with significant distal flow disturbance at the target arterial lesion when successful reperfusion was achieved,[6](#acn3536-bib-0006){ref-type="ref"}, [12](#acn3536-bib-0012){ref-type="ref"}, [13](#acn3536-bib-0013){ref-type="ref"} and (2) transient visualization of eccentric plaque contour or a recurrent reocclusion tendency in cases wherein reperfusion was unsuccessful.[12](#acn3536-bib-0012){ref-type="ref"} When no evidence of ISAT was demonstrated, complete recanalization with no residual stenosis in BA, or an established source of embolism with or without reperfusion were categorized as embolism.[6](#acn3536-bib-0006){ref-type="ref"} Patients with a mild residual stenosis or an unsuccessful reperfusion, without an embolic source, were determined to have an undeterminable mechanism and excluded (Fig. [1](#acn3536-fig-0001){ref-type="fig"}).[12](#acn3536-bib-0012){ref-type="ref"} Determination of stroke mechanism was performed by two neurologists (KHJ, 16 years of experience and WJL, 5 years of experience) independently of each other, blinded to all clinical information and MRI data. Inter‐observer agreement of the stroke mechanism determination was evaluated using Cohen\'s weighted Kappa. In cases of discrepancy, stroke mechanism was decided by consensus.

![Algorithm used to determine stroke mechanism. BA: basilar artery, mTICI: modified‐Thrombolysis in Cerebral Infarction, ISAT: in situ atherosclerotic thrombosis.\
^a^Presence of a cardiac source with high primary risk for ischemic stroke, listed in the SSS‐TOAST classification algorithm, *or a* ≥ 50% stenosis or a fresh thrombus on atherosclerotic plaque in proximal arteries, *or* a vertebral artery dissection, *or* a systemic coagulopathy associated with cancer or rheumatic disease.](ACN3-5-357-g001){#acn3536-fig-0001}

The source of embolism included a cardiac source with high primary risk for ischemic stroke, listed in the SSS‐TOAST classification algorithm,[12](#acn3536-bib-0012){ref-type="ref"} *a* ≥ 50% stenosis or a fresh thrombus on atherosclerotic plaque in proximal arteries, a dissection in vertebral arteries,[6](#acn3536-bib-0006){ref-type="ref"}, [11](#acn3536-bib-0011){ref-type="ref"}, [12](#acn3536-bib-0012){ref-type="ref"} and a systemic coagulopathy associated with cancer or rheumatic disease. To establish the source of embolism, we investigated continuous electrocardiography monitoring during the acute stroke phase, transthoracic echocardiography (TTE), and, if available, 24‐h heart‐rate monitoring, aortic CT angiography, or transesophageal echocardiography (TEE) performed in‐hospital or during follow‐up after discharge.[12](#acn3536-bib-0012){ref-type="ref"} Conventional TOAST classification of the study population was also evaluated.[13](#acn3536-bib-0013){ref-type="ref"}

Angiography data {#acn3536-sec-0010}
----------------

The time from stroke onset to groin puncture (onset‐to‐treatment) were categorized into \<3, 3--6, 6--9, and \>9 h throughout the analyses, according to the previous studies.[2](#acn3536-bib-0002){ref-type="ref"}, [4](#acn3536-bib-0004){ref-type="ref"} The location of BA occlusion was classified into proximal, middle, and distal, according to the most inferior extent of the obstruction. A proximal, middle, and distal BA segments were separated by the levels of the ramifications of the anterior‐inferior cerebellar arteries (AICAs) and the superior cerebellar arteries (SCAs), respectively.[4](#acn3536-bib-0004){ref-type="ref"}, [14](#acn3536-bib-0014){ref-type="ref"}

Baseline collateral status was evaluated by the American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology (ASITN/SIR) collateral grading system using four‐vessel angiography.[15](#acn3536-bib-0015){ref-type="ref"} Collateral scores were categorized into ASITN/SIR scores 0--1, 2, and 3--4.[4](#acn3536-bib-0004){ref-type="ref"} Reperfusion status was assessed using the modified Thrombolysis in Cerebral Infarction (mTICI) scale.[15](#acn3536-bib-0015){ref-type="ref"} Successful reperfusion was defined as an mTICI score of 2b--3.[4](#acn3536-bib-0004){ref-type="ref"}, [5](#acn3536-bib-0005){ref-type="ref"}, [15](#acn3536-bib-0015){ref-type="ref"} The duration of EVT was defined as the time from groin puncture to the last angiographic series.[4](#acn3536-bib-0004){ref-type="ref"} ASITN/SIR and mTICI scores were evaluated by a radiologist (YJR, 6 years of experience) and a neurologist (WJL), independently of each other, blinded to all clinical information and MRI data. In cases of discrepancy, consensus was made by the two evaluators. Inter‐observer agreements were evaluated using Cohen\'s weighted Kappa.

Clot sign analysis {#acn3536-sec-0011}
------------------

Pre‐angiography MRI was performed using 1.5‐T or 3‐T scanners (Intera Achieva; Philips Medical Systems, Best, the Netherlands;, Signa Excite; GE Medical Systems, Milwaukee, WI, USA; and Verio; Siemens Medical Solutions, Erlangen, Germany) with an eight‐channel head coil. MRI protocols included diffusion‐weighted imaging (DWI), fluid‐attenuated inversion recovery (FLAIR), gradient‐echo (GRE) or susceptibility‐weighted imaging (SWI), intracranial time‐of‐flight (TOF) angiography, and neck angiography. The MRI parameters were as follows: 3800--5000/45--60 msec (TR \[repetition time\]/TE \[echo time\]) for DWI; 690--1100/15--24 msec for GRE; 28/20 msec for SWI; 9000--9900/97--162.9 msec for FLAIR; and 20--25/3--7 msec for both the intracranial TOF and neck angiography. The other parameters were as follows: section thickness, 5 mm with a 1 mm gap and field‐of‐view, 240 × 240 mm.

The clot sign was defined as a hypo‐intense signal within a vascular lumen at the level of occlusion with a diameter that exceeded that of the vessel proximal to the occlusion, on the GRE sequences in 161 patients.[16](#acn3536-bib-0016){ref-type="ref"} In 30 patients, SWI sequences were used for the clot sign analyses, based on that SWI images are more sensitive in detecting blood signals than GRE.[17](#acn3536-bib-0017){ref-type="ref"} The location profile of clots signs was classified into proximal, middle, and distal, according to the most distal part of the clot sign in the BA segment,[14](#acn3536-bib-0014){ref-type="ref"} by a radiologist (YJR) and a neurologist (WJL), blinded to all clinical information and angiography data. In cases of discrepancy, consensus was made by the two evaluators.

Outcome parameter {#acn3536-sec-0012}
-----------------

We designated the modified Rankin Scale at 90 days (mRS90) evaluated by the referring physician as the main outcome in this study. A favorable mRS90 was defined as a score of 0--2 and a poor mRS90 as a score of 3--6.

Statistical analysis {#acn3536-sec-0013}
--------------------

SPSS (version 22.0; SPSS Inc., Chicago, IL, USA) was used for all statistical analyses. Data were reported as numbers (percentages), means ± standard deviations, or medians \[interquartile ranges, IQR\]. Student\'s *t*‐test was used to compare continuous variables. Categorical variables were compared using Pearson\'s chi‐square test. In every analysis, a two‐tailed *P*‐value \<0.05 was regarded as statistically significant.

To evaluate the association of stroke mechanism with the clinical outcomes, a logistic regression analysis including the stroke mechanism and the previously recognized outcome parameters such as age, hypertension, NIHSS scores, location of occlusion, collateral status, onset‐to‐treatment time, and reperfusion/recanalization,[2](#acn3536-bib-0002){ref-type="ref"}, [4](#acn3536-bib-0004){ref-type="ref"}, [5](#acn3536-bib-0005){ref-type="ref"}, [7](#acn3536-bib-0007){ref-type="ref"}, [10](#acn3536-bib-0010){ref-type="ref"}, [14](#acn3536-bib-0014){ref-type="ref"}, [18](#acn3536-bib-0018){ref-type="ref"}, [19](#acn3536-bib-0019){ref-type="ref"}, [20](#acn3536-bib-0020){ref-type="ref"} as well as the parameters with a *P* \< 0.20 in univariate analysis, was performed for the entire study population using a full model fit. Then, a full model fit logistic regression analyses for the outcome factors were performed again separately in each group of stroke mechanism.

To identify the pre‐angiographically available parameters which might be useful to discriminate the underlying stroke mechanism, logistic regression analyses were performed with a model‐building method.[21](#acn3536-bib-0021){ref-type="ref"} The clinical and MRI parameters with a potential significance (*P* \< 0.20) were introduced into serial regression analyses in backward step‐down methods, deleting the variable with the largest *P* (if ≥0.05) from the next step.[22](#acn3536-bib-0022){ref-type="ref"} Using the likelihood ratio statistics, a model with the lowest model chi‐square was accepted. Pearson chi‐square, deviance, and Hosmer‐Lemeshow tests were evaluated to assess the goodness of fit.[23](#acn3536-bib-0023){ref-type="ref"} Model sensitivity and specificity to predict underlying stroke mechanism were also calculated.

Results {#acn3536-sec-0014}
=======

Among the 201 patients initially included in the study, seven patients with undetermined mechanism were excluded. The remaining 194 patients (mean age 68.8 ± 11.8, range 21--92 years) were included in the final analysis. According to the algorithm used, 92 (47.4%) patients were classified as the ISAT mechanism and 102 (52.6%) as the embolic mechanism (Fig. [1](#acn3536-fig-0001){ref-type="fig"}). To investigate the source of cardioembolism, TTE was performed in 177 (91.2%) s, 24‐h heart‐rate monitoring in 92 (47.4%), and TEE and/or aortic CT angiography in 30 (15.5%) patients. TEE and/or aortic CT angiography was performed more frequently in the embolism group and 24‐h heart‐rate monitoring was performed more frequently in the ISAT group (Table [1](#acn3536-tbl-0001){ref-type="table-wrap"}). The inter‐observer agreement of mechanism determination was excellent (0.92, 95% confidence interval \[95% CI\]:0.86--0.97). The profiles of embolic sources and TOAST classification in each stroke mechanism are summarized in Table [1](#acn3536-tbl-0001){ref-type="table-wrap"}.

###### 

Workup for cardioembolism, embolic sources, and TOAST classification profiles in each stroke mechanism

                                                                                                         In situ atherosclerotic thrombosis (*N* = 92)   Embolism (*N* = 102)   *P*
  ------------------------------------------------------------------------------------------------------ ----------------------------------------------- ---------------------- --------------------------------------------------
  Work up for an embolism source                                                                                                                                                
  Work up profiles                                                                                                                                                              
  Diagnosed without additional workup                                                                    18 (19.6)                                       67 (65.7)              \<0.001[\*\*](#acn3536-note-0002){ref-type="fn"}
  Transthoracic echocardiography                                                                         81 (88.0)                                       96 (94.1)              0.143
  24‐h heart‐rate monitoring                                                                             58 (63.0)                                       34 (33.3)              \<0.001[\*\*](#acn3536-note-0002){ref-type="fn"}
  Transesophageal echocardiography/aortic CT angiography                                                 8 (8.7)                                         22 (21.6)              0.012[\*](#acn3536-note-0002){ref-type="fn"}
  Embolism source profile                                                                                                                                                       
  Embolism source overall                                                                                25 (27.2)                                       96 (94.1)              \<0.001[\*\*](#acn3536-note-0002){ref-type="fn"}
  Atrial fibrillation                                                                                    18 (19.6)                                       70 (68.6)              \<0.001[\*\*](#acn3536-note-0002){ref-type="fn"}
  Cardioembolic high‐risk sources other than atrial fibrillation[1](#acn3536-note-0003){ref-type="fn"}   2 (2.2)                                         16 (15.7)              0.001[\*\*](#acn3536-note-0002){ref-type="fn"}
  Embolic sources in proximal arteries[2](#acn3536-note-0004){ref-type="fn"}                             7 (7.6)                                         21 (20.6)              0.009[\*\*](#acn3536-note-0002){ref-type="fn"}
  Systemic hypercoagulability[3](#acn3536-note-0005){ref-type="fn"}                                      1 (1.1)                                         4 (3.9)                0.203
  TOAST classification                                                                                                                                                          
  Large‐artery atherosclerosis                                                                           73 (79.3)                                       21 (20.6)              \<0.001[\*\*](#acn3536-note-0002){ref-type="fn"}
  Cardioembolism                                                                                         0 (0.0)                                         71 (69.6)              \<0.001[\*\*](#acn3536-note-0002){ref-type="fn"}
  Other determined                                                                                       0 (0.0)                                         1 (1.0)                0.344
  Undetermined (≥2 causes)                                                                               19 (20.7)                                       3 (2.9)                \<0.001[\*\*](#acn3536-note-0002){ref-type="fn"}
  Undetermined (negative)                                                                                0 (0.0)                                         5 (4.9)                0.025[\*](#acn3536-note-0002){ref-type="fn"}
  Undetermined (incomplete)                                                                              0 (0.0)                                         1 (1.0)                0.344

Data are reported as number (percentage). \**P* \< 0.05, \*\**P* \< 0.01.

^1^ Seven with a mitral valve disease with a replacement surgery, four with dilated cardiomyopathy, four with a thrombus or a myxoma in left atrium, three with a large right‐to‐left shunt, and two with an akinetic left ventricular segment.

^2^ Twenty patients with *a* ≥ 50% stenosis, six with a dissection, and two with a thrombosed aneurysm in proximal arteries.

^3^ Three patients with cancer‐related hypercoagulability and two with hypercoagulability‐associated with rheumatic diseases.
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The median initial NIHSS score was 16 \[7--25\]. Pre‐angiographic stage MRI was performed at 326.2 ± 377.4 min from onset and the clot sign was detected in 181 (93.3%) patients. Angiography was performed at 371.0 ± 271.0 min from onset. Baseline collateral status was evaluable in 184 (94.8%) patients and the median ASITN/SIR grade was 2 \[1--3\]. For EVT, a stent retriever was used in 142 (73.2%) patients and 35 (18.0%) patients underwent IA thrombolysis. After 74.8 ± 61.3 min duration of EVT, the median mTICI score was 2b \[2a--3\], and successful reperfusion was achieved in 137 (70.6%) patients. The inter‐observer agreements of ASITN/SIR and mTICI scores were good (0.69; 95% CI: 0.61--0.79 and 0.72; 95% CI: 0.65--0.80, respectively). The median mRS90 was 3 \[2--5\], and 127 (65.5%) patients had poor outcomes.

In the logistic regression analysis for the outcome predictors, a poor functional outcome was significantly associated with the ISAT mechanism compared to embolism (Odds ratio \[OR\]: 4.10, 95% CI: 1.67--9.92, *P* = 0.002), along with the NIHSS scores (*P* \< 0.001), reperfusion status (*P* = 0.005), and ASITN/SIR grades (*P* = 0.006, Table [2](#acn3536-tbl-0002){ref-type="table-wrap"}, see Table [3](#acn3536-tbl-0003){ref-type="table-wrap"} for the univariate analysis).

###### 

Multivariate analyses for a poor outcome

                                          Odds ratio   95% CI       *P*
  --------------------------------------- ------------ ------------ --------------------------------------------------
  Stroke mechanism (ISAT to embolism)     4.10         1.67--9.92   0.002[\*\*](#acn3536-note-0006){ref-type="fn"}
  NIHSS scores                            1.14         1.08--1.20   \<0.001[\*\*](#acn3536-note-0006){ref-type="fn"}
  Successful reperfusion                  0.28         0.11--0.68   0.005[\*\*](#acn3536-note-0006){ref-type="fn"}
  Collateral status grade (categorized)   0.50         0.31--0.82   0.006[\*\*](#acn3536-note-0006){ref-type="fn"}

ISAT: In situ atherosclerotic thrombosis, NIHSS: NIH Stroke‐Scale, CI: confidence interval. \*\**P* \< 0.01. Incorporated parameters are: stroke mechanism, age, male sex, hypertension, NIHSS scores, location of occlusion, collateral status grade, onset‐to‐treatment time, and reperfusion. Recanalization, use of combined modality and anticoagulation were not included because they are largely influenced by the reperfusion status.

John Wiley & Sons, Ltd

###### 

Intergroup comparisons of demographic, clinical, radiologic, treatment and outcome profiles

                                                                  Good outcomes mRS90 0--2 (*N* = 87)   Poor outcomes mRS90 3--6 (*N* = 107)   *P*
  --------------------------------------------------------------- ------------------------------------- -------------------------------------- --------------------------------------------------
  Demographic and clinical profiles                                                                                                            
  Age                                                             65.7 ± 11.1                           71.2 ± 11.9                            0.001[\*](#acn3536-note-0007){ref-type="fn"}
  Male sex                                                        56 (64.4)                             60 (56.1)                              0.168
  Previous stroke history                                         22 (25.3)                             33 (30.8)                              0.392
  Hypertension                                                    53 (60.9)                             79 (73.8)                              0.055
  Diabetes mellitus                                               25 (28.7)                             34 (31.8)                              0.647
  Smoking in past 5 years                                         21 (24.1)                             19 (17.8)                              0.276
  Hyperlipidemia                                                  14 (16.1)                             15 (14.0)                              0.688
  Antithrombotic use prior to attack                              37 (42.5)                             44 (41.1)                              0.843
  NIHSS scores (IQR)                                              8 (5--16)                             23 (14--28)                            \<0.001[\*\*](#acn3536-note-0007){ref-type="fn"}
  Stroke mechanism                                                                                                                             0.017[\*](#acn3536-note-0007){ref-type="fn"}
  In situ atherosclerotic thrombosis                              33 (37.9)                             59 (55.1)                              
  Embolism                                                        54 (62.1)                             48 (44.9)                              
  MRI and angiographic profiles                                                                                                                
  Onset to MRI (minutes)[a](#acn3536-note-0007){ref-type="fn"}    337.8 ± 334.0                         318.2 ± 310.5                          0.714
  Clot sign[a](#acn3536-note-0007){ref-type="fn"}                 79 (90.8)                             102 (95.3)                             0.317
  Location of occlusion                                                                                                                        0.008[\*](#acn3536-note-0007){ref-type="fn"}
  Proximal                                                        31 (35.6)                             49 (45.8)                              
  Middle                                                          22 (25.3)                             35 (32.7)                              
  Distal                                                          34 (39.1)                             23 (21.5)                              
  Collateral status grade[b](#acn3536-note-0007){ref-type="fn"}                                                                                \<0.001[\*\*](#acn3536-note-0007){ref-type="fn"}
  ASITN/SIR grade 0--1                                            15 (17.2)                             45 (42.1)                              
  ASITN/SIR grade 2                                               21 (24.1)                             33 (30.8)                              
  ASITN/SIR grade 3--4                                            47 (54.0)                             23 (21.5)                              
  Treatment profiles                                                                                                                           
  Onset to treatment (minutes)                                                                                                                 0.254
  \<3 h                                                           27 (31.0)                             22 (20.6)                              
  3--6 h                                                          28 (32.2)                             46 (43.0)                              
  6--9 h                                                          15 (17.2)                             15 (14.0)                              
  \>9 h                                                           17 (19.5)                             24 (22.4)                              
  Treatment modality                                                                                                                           
  Intravenous thrombolysis                                        25 (28.7)                             27 (25.2)                              0.584
  IA thrombolysis                                                 20 (23.0)                             15 (14.0)                              0.133
  Stent retriever                                                 61 (70.1)                             81 (75.7)                              0.383
  Angioplasty/stent                                               14 (16.1)                             20 (18.7)                              0.635
  Combined modality[1](#acn3536-note-0008){ref-type="fn"}         54 (62.1)                             76 (71.0)                              0.187
  Reperfusion status                                                                                                                           \<0.001[\*\*](#acn3536-note-0007){ref-type="fn"}
  mTICI 0--2a                                                     11 (12.6)                             46 (43.0)                              
  mTICI 2b--3                                                     76 (87.4)                             61 (57.0)                              
  Recanalization status                                                                                                                        0.023[\*](#acn3536-note-0007){ref-type="fn"}
  AOL 0--2                                                        42 (48.3)                             69 (64.5)                              
  AOL 3                                                           45 (51.7)                             38 (45.5)                              
  Duration of angiography (minutes)                               55.2 ± 40.2                           90.7 ± 70.5                            \<0.001[\*\*](#acn3536-note-0007){ref-type="fn"}
  Anticoagulation                                                 35 (40.2)                             32 (29.9)                              0.133
  Combined antithrombotic agents                                  57 (65.5)                             65 (60.7)                              0.494
  Delayed reocclusion                                             4 (4.6)                               11 (10.3)                              0.131

Data are reported as number (percentage), as mean ± standard deviation, or as median (interquartile range, IQR). NIHSS: NIH Stroke‐Scale, MRI: magnetic resonance image, ASITN/SIR: American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology, mTICI: modified Thrombolysis in Cerebral Infarction Scale, AOL: arterial occlusive lesion scale, mRS90: modified Rankin Scale score at 90 days. \**P* \< 0.05. \*\**P* \< 0.01. Datasets available: ^a^ *n* = 191, ^b^ *n* = 184.

^1^ Combined modality: using two or more modalities during endovascular (intra‐arterial) treatment.
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The two underlying mechanisms had a substantial difference on the outcome parameters. In the embolism group, reperfusion (*P* = 0.001), NIHSS scores (*P* \< 0.001), and a longer onset‐to‐treatment time (*P* = 0.030) were significant outcome factors. However, in the ISAT group, the collateral status grades (*P* = 0.001) and NIHSS scores (*P* \< 0.001) were significantly associated with a poor mRS90, while the reperfusion status or the onset‐to‐treatment time were not significantly associated with outcomes (Table [4](#acn3536-tbl-0004){ref-type="table-wrap"} and Fig. [S1](#acn3536-sup-0001){ref-type="supplementary-material"}, see Table [S1](#acn3536-sup-0001){ref-type="supplementary-material"} for the univariate analyses).

###### 

Multivariate analyses for outcome, separated by underlying mechanism

  mRS90 3--6                                      Odds ratio   95% CI       *P*
  ----------------------------------------------- ------------ ------------ --------------------------------------------------
  Embolism (*N* = 102)                                                      
  NIHSS scores                                    1.16         1.09--1.24   \<0.001[\*\*](#acn3536-note-0009){ref-type="fn"}
  Onset to treatment (categorized)                2.04         1.07--3.89   0.030[\*](#acn3536-note-0009){ref-type="fn"}
  Successful reperfusion                          0.03         0.00--0.24   0.001[\*\*](#acn3536-note-0009){ref-type="fn"}
  In situ atherosclerotic thrombosis (*N* = 92)                             
  NIHSS scores                                    1.21         1.10--1.34   \<0.001[\*\*](#acn3536-note-0009){ref-type="fn"}
  Collateral status grade (categorized)           0.20         0.08--0.54   0.001[\*\*](#acn3536-note-0009){ref-type="fn"}

mRS90: modified Rankin‐Scale score at 90 days, NIHSS: NIH Stroke‐Scale, CI: confidence interval. \**P* \< 0.05, \*\**P* \< 0.01. Incorporated parameters in each analysis are: stroke mechanism, age, male sex, hypertension, NIHSS scores, location of occlusion, collateral status grade, onset‐to‐treatment time, and reperfusion. Recanalization, use of combined modality and anticoagulation were not included because they are largely influenced by the reperfusion status.

John Wiley & Sons, Ltd

In the study population, 12 patients with a stenosis of \<50% and a coexisting embolic source were categorized into the embolism group.[12](#acn3536-bib-0012){ref-type="ref"}, [13](#acn3536-bib-0013){ref-type="ref"} When outcome analyses were re‐performed after excluding those patients, the remaining 182 patients had the same profiles of outcome parameters with the original population. (Tables [S2](#acn3536-sup-0001){ref-type="supplementary-material"} and [S3](#acn3536-sup-0001){ref-type="supplementary-material"}). Additionally, the outcome factors in the embolism group (90 patients) were also same with those of the original population (Table [S3](#acn3536-sup-0001){ref-type="supplementary-material"}).

The two underlying mechanisms also exhibited a substantial difference on the clinical, radiologic, and outcome profiles. Compared to embolism, ISAT was associated with a lower initial NIHSS scores, longer onset‐to‐treatment time, less frequent use of intravenous thrombolysis, more frequent use of angioplasty/stent, longer duration of angiography, and less successful reperfusion (Table [5](#acn3536-tbl-0005){ref-type="table-wrap"}). Especially, ISAT was associated with more proximal location of occlusion on angiography and more proximal involvement of clot signs, compared to embolism (all, *P* \< 0.001).

###### 

Intergroup comparisons of demographic, clinical, radiologic, treatment and outcome profiles

                                                                  In situ atherosclerotic thrombosis (*N* = 92)   Embolism (*N* = 102)   *P*
  --------------------------------------------------------------- ----------------------------------------------- ---------------------- --------------------------------------------------
  Demographic and clinical profiles                                                                                                      
  Age                                                             70.2 ± 10.6                                     67.4 ± 12.7            0.088
  Male sex                                                        49 (53.3)                                       67 (65.7)              0.078
  Previous stroke history                                         30 (32.6)                                       25 (24.5)              0.211
  Hypertension                                                    62 (67.4)                                       70 (68.6)              0.722
  Diabetes mellitus                                               30 (32.6)                                       29 (28.4)              0.528
  Smoking in past 5 years                                         18 (19.6)                                       22 (21.6)              0.730
  Hyperlipidemia                                                  15 (16.3)                                       14 (13.7)              0.511
  NIHSS scores (IQR)                                              12 (6--24.75)                                   19.5 (9.75--26.25)     0.007[\*](#acn3536-note-0010){ref-type="fn"}
  MRI and angiographic profiles                                                                                                          
  Clot signs[a](#acn3536-note-0010){ref-type="fn"}                85 (92.4)                                       96 (94.1)              0.161
  Clot sign present at[b](#acn3536-note-0010){ref-type="fn"}                                                                             \<0.001[\*\*](#acn3536-note-0010){ref-type="fn"}
  Distal BA segment                                               5 (5.4)                                         86 (84.3)              
  Middle BA segment                                               50 (54.3)                                       10 (9.8)               
  Proximal BA segment                                             30 (32.6)                                       0 (0.0)                
  Onset to treatment (minutes)                                    466.5 ± 291.2                                   277.0 ± 204.7          \<0.001[\*\*](#acn3536-note-0010){ref-type="fn"}
  Location of occlusion                                                                                                                  \<0.001[\*\*](#acn3536-note-0010){ref-type="fn"}
  Proximal                                                        64 (69.6)                                       16 (15.7)              
  Middle                                                          26 (28.3)                                       31 (30.4)              
  Distal                                                          2 (2.2)                                         55 (53.9)              
  Collateral status grade[c](#acn3536-note-0010){ref-type="fn"}                                                                          0.316
  ASITN/SIR grade 0--1                                            23 (25.0)                                       37 (36.3)              
  ASITN/SIR grade 2                                               29 (31.5)                                       25 (4.5)               
  ASITN/SIR grade 3--4                                            34 (37.0)                                       36 (35.3)              
  Treatment/outcome profiles                                                                                                             
  Treatment                                                                                                                              
  Intravenous thrombolysis                                        12 (13.0                                        40 (39.2)              \<0.001[\*\*](#acn3536-note-0010){ref-type="fn"}
  Stent retriever                                                 65 (70.7)                                       77 (75.5)              0.448
  IA thrombolysis                                                 16 (17.4)                                       19 (18.6)              0.823
  Angioplasty/stent                                               29 (31.5)                                       5 (4.9)                0.001[\*\*](#acn3536-note-0010){ref-type="fn"}
  Combined modality[1](#acn3536-note-0011){ref-type="fn"}         67 (72.8)                                       63 (61.8)              0.101
  Successful reperfusion                                          51 (55.4)                                       86 (84.3)              \<0.001[\*\*](#acn3536-note-0010){ref-type="fn"}
  Duration of angiography (minutes)                               87.4 ± 67.6                                     63.2 ± 52.1            0.006[\*\*](#acn3536-note-0010){ref-type="fn"}

Data are reported as number (percentage), as mean ± standard deviation, or as median \[interquartile range, IQR\]. NIHSS: NIH Stroke‐Scale, ASITN/SIR: American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology. \**P* \< 0.05, \*\**P* \< 0.01. Datasets available: ^a^ *n* = 191, ^b^ *n* = 181, ^c^ *n* = 184.

^1^ Combined modality: using two or more modalities during endovascular (intra‐arterial) treatment.

John Wiley & Sons, Ltd

The multivariate logistic regression to identify the pre‐angiographically available parameters associated with the underlying stroke mechanism resulted in a model with a single variable, a clot sign at the distal BA segment (OR: 115.11, 95% CI: 39.34--336.79, *P* \< 0.001, Table [6](#acn3536-tbl-0006){ref-type="table-wrap"}), that best predicted an embolism mechanism. Parameters for the goodness--of‐fit tests were not significant; 86/91 (94.5%) patients with a clot sign at distal basilar segment had an embolic mechanism, whereas 80/90 (88.9%) patients without a clot sign at distal basilar segment were associated with an ISAT (both, *P* \< 0.001, Fig. [2](#acn3536-fig-0002){ref-type="fig"}). The inter‐reader agreement of the analyses of clot sign location was excellent (0.82, 95% CI 0.78--0.88). When the regression analyses were performed separately for the subpopulations that used GRE or SWI sequences, the same results were deduced (OR: 58.21, 95% CI: 20.00--169.44, *P* \< 0.001 for GRE \[*n* = 161\] and OR: 76.92, 95% CI: 6.13--965.19, *P* \< 0.001 for SWI \[*n* = 30\]).

###### 

Multivariate analysis for clinical and MRI parameters associated with underlying mechanism

  Embolism to in situ atherosclerosis   Odds ratio   95% CI          *P*
  ------------------------------------- ------------ --------------- --------------------------------------------------
  Clot sign (+) at distal BA segment    115.11       39.34--336.79   \<0.001[\*\*](#acn3536-note-0012){ref-type="fn"}

BA, basilar artery, CI; confidence interval. \*\**P* \< 0.01.

John Wiley & Sons, Ltd

![Representative cases. A 60‐year‐old male patient with initial NIH Stroke‐Scale (NIHSS) score of 18. In axial gradient‐echo images (GRE) of initial MRI, a clot in the proximal basilar segment is observed (panel A). Angiography reveals a basilar artery (BA) occlusion at the vertebra‐basilar junction level (panel B, upper). Immediate follow‐up angiography after achieving a successful reperfusion by endovascular treatment revealed a tight residual stenosis in the proximal BA, suggesting an in situ atherosclerotic stenosis mechanism (panel B, lower). In GRE images of an 85‐year‐old female patient with initial NIHSS score of 21, clot sign was detected in the distal basilar segment (panel C). BA was occluded at the middle segment (panel D, upper), and no residual stenosis was observed after a complete reperfusion, suggesting an embolic mechanism (panel D, lower).](ACN3-5-357-g002){#acn3536-fig-0002}

Discussion {#acn3536-sec-0015}
==========

This study demonstrated that underlying mechanism has a substantial influence on the clinical profiles of BA occlusion and the outcomes after EVT. Furthermore, each stroke mechanism had distinct outcome factors, with outcomes of ISAT being associated with baseline collateral status, and outcomes of embolism with onset‐to‐treatment time and reperfusion status. Additionally, the presence of clot signs in the distal BA segment on axial GRE or SWI images of pre‐angiography MRI was strongly associated with an embolism mechanism.

Numerous studies have assessed the outcome predictors of BA occlusion after thrombolysis. While initial stroke severity has been repeatedly recognized as an outcome parameter, other factors such as atrial fibrillation,[5](#acn3536-bib-0005){ref-type="ref"} location of BA obstruction,[19](#acn3536-bib-0019){ref-type="ref"} onset‐to‐treatment time,[4](#acn3536-bib-0004){ref-type="ref"}, [5](#acn3536-bib-0005){ref-type="ref"}, [24](#acn3536-bib-0024){ref-type="ref"} and reperfusion[4](#acn3536-bib-0004){ref-type="ref"}, [8](#acn3536-bib-0008){ref-type="ref"}, [18](#acn3536-bib-0018){ref-type="ref"}, [19](#acn3536-bib-0019){ref-type="ref"}, [25](#acn3536-bib-0025){ref-type="ref"} were only inconsistently associated with outcomes. While the importance of collateral status and successful reperfusion is well established in anterior circulation,[26](#acn3536-bib-0026){ref-type="ref"} their implications have remained inconclusive in BA occlusive strokes.[4](#acn3536-bib-0004){ref-type="ref"} This might be attributable to the substantial impact of underlying stroke mechanism on the clinical behaviors and outcomes of BA occlusion, as ISAT mechanism is associated with milder initial severity, a longer onset‐to‐treatment time, lower response to endovascular treatment, and subsequent poorer long‐term outcomes, compared to the embolism, as observed in this study and previous reports.[6](#acn3536-bib-0006){ref-type="ref"}, [24](#acn3536-bib-0024){ref-type="ref"}

Previous studies using the TOAST classification reported that stroke mechanism was not significantly associated with the outcomes.[4](#acn3536-bib-0004){ref-type="ref"}, [5](#acn3536-bib-0005){ref-type="ref"}, [7](#acn3536-bib-0007){ref-type="ref"} A considerable difference in the classification result between the TOAST and the algorithm used in this study might be a possible explanation. Twenty‐one out of ninety‐four (22.3%) of patients classified as a large‐artery atherosclerosis in TOAST classification were classified as embolism in this study, as they had a source of artery‐to‐artery embolism in the proximal arteries with atheromatous plaque. Twenty‐nine patients with undetermined or other‐determined mechanisms according to the TOAST criteria were also classified as either ISAT or embolism. This might suggest that the classification used in this study might appropriately reflect the underlying pathophysiology and clinical behaviors of the BA occlusive strokes.

Recently, a similar study regarding acute BA occlusion with endovascular treatment found no differences in recanalization rate and outcome between patients with and without underlying ISAT.[27](#acn3536-bib-0027){ref-type="ref"} However, the criterion for an ISAT used in that study was a severe (≥70%) stenosis of BA on the initial diagnostic angiography or on the follow‐up angiography after a reperfusion procedure. Therefore, at least transient recanalization of the occluded BA was required to determine an ICAS mechanism, unless the patient was diagnosed as a severe BA stenosis previously to the stroke event. In this regard, only 15/62 (24.2%) patients were classified as ISAT mechanism and all of them (15/15, 100%) achieved a successful reperfusion. As unsuccessful reperfusion is frequently associated with underlying ISAT mechanism, criteria of determining ISAT in the cases of unsuccessful reperfusion are necessary. In this study, transient visualization of eccentric plaque contour or recurrent reocclusion tendency was used as the criteria for ISAT. However, a careful discrimination of mechanism is warranted especially for the cases with unsuccessful reperfusion, although the inter‐observer agreement of mechanism determination was excellent.

In this study, onset‐to‐treatment time, collateral grade, and reperfusion statuses had discriminative impacts on outcomes according to stroke mechanism. In ISAT, collateral flow of the BA may have developed during the progression of atherosclerosis to compensate diminishing flow in the BA, resulting in BA territory perfusion that is not dependent on the patency of the BA.[28](#acn3536-bib-0028){ref-type="ref"}, [29](#acn3536-bib-0029){ref-type="ref"} Thus, the integrity of the backup collateral system, which might be related to the instability and the speed of plaque progression, would have more dominant influence on outcomes than the recanalization of BA itself. In this regard, onset‐to‐treatment time for a reperfusion therapy might not significantly influence the outcomes in ISAT. Meanwhile, in embolism, sudden deterioration of flow does not provide adequate time for the development of collateral flow. Therefore, fast and complete reperfusion of the BA might have a fundamental value, which explains that onset‐to‐treatment time and successfulness of reperfusion were recognized as significant factors for outcomes in this study.[5](#acn3536-bib-0005){ref-type="ref"}, [8](#acn3536-bib-0008){ref-type="ref"}, [18](#acn3536-bib-0018){ref-type="ref"}, [19](#acn3536-bib-0019){ref-type="ref"}, [24](#acn3536-bib-0024){ref-type="ref"}, [25](#acn3536-bib-0025){ref-type="ref"}

Different strategies and treatment goals should be set according to the underlying mechanisms. For ISAT, angiography should include an evaluation of baseline collateral circulation, multiple modalities should be prepared to raise the possibility of successful reperfusion, and acute management after thrombolysis should focus on hemodynamic issues. However, for embolic strokes, minimizing the delay and optimizing the modalities to achieve a prompt and successful reperfusion might be the primary goal.

In this regard, analyzing the location profile of the BA occlusion is useful in early discrimination of stroke mechanism. As turbulent flow is mainly formed at vertebra‐basilar junctions,[30](#acn3536-bib-0030){ref-type="ref"} this site is the most frequent location of atherosclerotic plaque development. In contrast, as the BA has vertebral arteries in its proximity and posterior cerebral arteries (PCAs) distally of which luminal diameters were smaller than BA,[31](#acn3536-bib-0031){ref-type="ref"} an embolus drifting from the proximal vessels usually get stuck in the branching site between the BA and PCAs. Moreover, as the BA system has abundant collateral system including the retrograde flow from posterior communicating arteries, clot growth due to the obstruction‐related blood stasis might dominantly develop to caudal directions.[9](#acn3536-bib-0009){ref-type="ref"} Therefore, the location of the distal portion of clot sign might more properly represent the primary occlusion site than the proximal portion of clot, which explains how the presence of clot signs in the distal BA segment well correlates with an embolism mechanism.[6](#acn3536-bib-0006){ref-type="ref"}, [11](#acn3536-bib-0011){ref-type="ref"}

This study possesses some limitations. First, the criteria used to determine stroke mechanism were not fully validated. Especially for the cases with unsuccessful reperfusion, an embolus with high fibrin components might mimic an eccentric atheromatous plaque, warranting a careful discrimination of mechanism. Second, different completeness of the embolic source evaluations between the groups might also influence the reliability of stroke mechanism determination. However, continuous electrocardiography monitoring was performed on every patient during the acute stroke phase and most of the patients received TTE as the basic evaluation. Additionally, 24‐h heart‐rate monitoring was performed more frequently in the ISAT group, which indicates that more thorough investigations were exerted to exclude an atrial fibrillation before determining and ISAT mechanism. Third, as EVT was performed according to the clinician\'s decision without a certain criteria being satisfied but a long time window, a selection bias might have been introduced in the study population. Fourth, the modalities and devices used in EVT were not standardized, which might have influenced the success of reperfusion. However, the types or numbers of modalities used in EVT showed no significant association with outcomes. A prospective study with homogenized treatment modalities and a predefined algorithm of mechanism classification is warranted to strengthen the findings of this study.

In conclusion, stroke mechanism has a significant impact on the clinical features and the outcomes in BA occlusion with endovascular reperfusion treatment. Analyzing the clot sign location on pre‐angiography MRI might be useful in the early determination of stroke mechanism.
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**Figure S1.** Impact of successful reperfusion and baseline collateral status on stroke outcomes in each stroke mechanism.

**Table S1.** Univariate analyses for an outcome parameter, separated by underlying stroke mechanism.

**Table S2.** Intergroup comparisons of demographic, clinical, radiologic, treatment, and outcome profiles, after excluding 12 patients with stenosis of less than 50% and coexisting embolic sources.

**Table S3.** Multivariate analyses for a poor outcome, after excluding 12 patients with stenosis of less than 50% and coexisting embolic sources.
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Click here for additional data file.
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